Literature DB >> 11818462

Cyclooxygenase-2: a therapeutic target.

Marco E Turini1, Raymond N DuBois.   

Abstract

Cyclooxygenase (COX), also known as prostaglandin endoperoxide synthase, is the key enzyme required for the conversion of arachidonic acid to prostaglandins. Two COX isoforms have been identified, COX-1 and COX-2. In many situations, the COX-1 enzyme is produced constitutively (e.g., in gastric mucosa), whereas COX-2 is highly inducible (e.g., at sites of inflammation and cancer). Traditional nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit both enzymes, and a new class of COX-2 selective inhibitors (COXIBs) preferentially inhibit the COX-2 enzyme. This review summarizes our current understanding of the role of COX-1 and COX-2 in normal physiology and disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818462     DOI: 10.1146/annurev.med.53.082901.103952

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  126 in total

1.  Virus self-improvement through inflammation: no pain, no gain.

Authors:  Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 2.  Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?

Authors:  Timothy D Warner; Jane A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

3.  Oxygen resuscitation after hypoxia ischemia stimulates prostaglandin pathway in rat cortex.

Authors:  J Regino Perez-Polo; Conor B Reilly; Harriet C Rea
Journal:  Int J Dev Neurosci       Date:  2011-04-14       Impact factor: 2.457

Review 4.  Recent methodologies toward the synthesis of valdecoxib: a potential 3,4-diarylisoxazolyl COX-II inhibitor.

Authors:  Sureshbabu Dadiboyena; Adel Nefzi
Journal:  Eur J Med Chem       Date:  2010-08-06       Impact factor: 6.514

5.  Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells.

Authors:  Shun-Fa Yang; Mu-Kuan Chen; Yih-Shou Hsieh; Tsung-Te Chung; Yi-Hsien Hsieh; Chiao-Wen Lin; Jen-Liang Su; Ming-Hsui Tsai; Chih-Hsin Tang
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

6.  Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells.

Authors:  Kuan-Min Fang; Chung-Shi Yang; Tzu-Chien Lin; Ti-Chun Chan; Shun-Fen Tzeng
Journal:  Neuro Oncol       Date:  2013-12-09       Impact factor: 12.300

7.  Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1).

Authors:  Gareth Sully; Jonathan L E Dean; Robin Wait; Lesley Rawlinson; Tomas Santalucia; Jeremy Saklatvala; Andrew R Clark
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

8.  Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients.

Authors:  M Ghavipour; G Sotoudeh; E Tavakoli; K Mowla; J Hasanzadeh; Z Mazloom
Journal:  Eur J Clin Nutr       Date:  2016-08-31       Impact factor: 4.016

9.  Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells.

Authors:  Lubna M Mehdawi; Chandra Prakash Prasad; Roy Ehrnström; Tommy Andersson; Anita Sjölander
Journal:  Mol Oncol       Date:  2016-08-01       Impact factor: 6.603

10.  Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: inefficacy of genetic or pharmacological disruption of COX-2.

Authors:  Louise Y Y Fong; Yubao Jiang; Maurisa Riley; Xianglan Liu; Karl J Smalley; Denis C Guttridge; John L Farber
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.